AI assistant
STAAR SURGICAL CO — Director's Dealing 2022
Mar 9, 2022
31996_dirs_2022-03-08_81ffc5c3-f5da-4bd4-80dc-97145116357e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-03-07
Reporting Person: Barnes Scott D (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-07 | Common Stock | M | 7991 | $0.00 | Acquired | 31317 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-03-07 | Common Stock Options | $74.80 | M | 16621 | Acquired | 2032-03-06 | Common Stock (16621) | Direct |
Footnotes
F1: Award of 7991Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the RSUs on 3/7/23, 1/3 of the RSUs on 3/7/24, and the remaining 1/3 of the RSUs on 3/7/25.
F2: The options granted become exercisable as follows: 1/3 on 3/7/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/7/2025.